These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30819762)

  • 21. An increase in murine skeletal muscle peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) mRNA in response to exercise is mediated by beta-adrenergic receptor activation.
    Miura S; Kawanaka K; Kai Y; Tamura M; Goto M; Shiuchi T; Minokoshi Y; Ezaki O
    Endocrinology; 2007 Jul; 148(7):3441-8. PubMed ID: 17446185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connective tissue growth factor/CCN2 attenuates β-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes.
    Gravning J; Ahmed MS; Qvigstad E; Krobert K; Edvardsen T; Moe IT; Hagelin EM; Sagave J; Valen G; Levy FO; Osnes JB; Skomedal T; Attramadal H
    Mol Pharmacol; 2013 Sep; 84(3):372-83. PubMed ID: 23778361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats.
    Ryall JG; Plant DR; Gregorevic P; Sillence MN; Lynch GS
    J Physiol; 2004 Feb; 555(Pt 1):175-88. PubMed ID: 14617677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
    Maruyama I; Goi Y; Tatemichi S; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):845-52. PubMed ID: 22552730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
    Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
    Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
    Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
    J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β
    Scholpa NE; Simmons EC; Tilley DG; Schnellmann RG
    Exp Neurol; 2019 Dec; 322():113064. PubMed ID: 31525347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting.
    Ryall JG; Lynch GS
    Pharmacol Ther; 2008 Dec; 120(3):219-32. PubMed ID: 18834902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clenbuterol and formoterol decrease force production in isolated intact mouse skeletal muscle fiber bundles through a beta2-adrenoceptor-independent mechanism.
    McCormick C; Alexandre L; Thompson J; Mutungi G
    J Appl Physiol (1985); 2010 Dec; 109(6):1716-27. PubMed ID: 20864554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.
    Suzuki H; Ueno A; Takei M; Sindo K; Miura T; Sakakibara M; Higa T; Fukamachi H
    Br J Pharmacol; 1999 Oct; 128(3):716-20. PubMed ID: 10516653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of overexpressed adenylyl cyclase VI on beta 1- and beta 2-adrenoceptor responses in adult rat ventricular myocytes.
    Stark JC; Haydock SF; Foo R; Brown MJ; Harding SE
    Br J Pharmacol; 2004 Oct; 143(4):465-76. PubMed ID: 15381636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reassertion profiles of long acting β2-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant β2-adrenoceptor.
    Patel S; Summerhill S; Stanley M; Perros-Huguet C; Trevethick MA
    Pulm Pharmacol Ther; 2011 Apr; 24(2):247-55. PubMed ID: 21134482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes.
    Pönicke K; Gröner F; Heinroth-Hoffmann I; Brodde OE
    Br J Pharmacol; 2006 Apr; 147(7):714-9. PubMed ID: 16474418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.
    Koopman R; Ryall JG; Church JE; Lynch GS
    Curr Opin Clin Nutr Metab Care; 2009 Nov; 12(6):601-6. PubMed ID: 19741516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR; Deng L; Tota L; Guan XM; Amend A; Liu Y; Newbold R; Cascieri MA; Weber AE
    J Pharmacol Exp Ther; 1999 Aug; 290(2):649-55. PubMed ID: 10411574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the bronchodilator and systemic effects of AZD3199, an inhaled ultra-long-acting β₂-adrenoceptor agonist, with formoterol in patients with asthma.
    Bjermer L; Rosenborg J; Bengtsson T; Lötvall J
    Ther Adv Respir Dis; 2013 Oct; 7(5):264-71. PubMed ID: 23907810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms involved in 3',5'-cyclic adenosine monophosphate-mediated inhibition of the ubiquitin-proteasome system in skeletal muscle.
    Gonçalves DA; Lira EC; Baviera AM; Cao P; Zanon NM; Arany Z; Bedard N; Tanksale P; Wing SS; Lecker SH; Kettelhut IC; Navegantes LC
    Endocrinology; 2009 Dec; 150(12):5395-404. PubMed ID: 19837877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of dexamethasone and clenbuterol on rat growth and on beta2-adrenoceptors in lung and skeletal muscle.
    Huang H; Gazzola C; Pegg GG; Sillence MN
    J Anim Sci; 2000 Mar; 78(3):604-8. PubMed ID: 10764067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of the extracellular cAMP-adenosine pathway to dual coupling of β2-adrenoceptors to Gs and Gi proteins in mouse skeletal muscle.
    Duarte T; Menezes-Rodrigues FS; Godinho RO
    J Pharmacol Exp Ther; 2012 Jun; 341(3):820-8. PubMed ID: 22438472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of β-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-α2-glycoprotien (ZAG).
    Russell ST; Tisdale MJ
    Biochim Biophys Acta; 2012 Apr; 1821(4):590-9. PubMed ID: 22227600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.